Freenome

According to a new report from the @AmericanCancer #CRC diagnoses are shifting rapidly to more advanced diseases and in younger people. Today, Freenome is attending a meeting at The White House for #CancerMoonshot. Watch live:
lnkd.in/gm7NGrVZ

From @AmericanCancer: colorectal cancer is the 3rd most commonly diagnosed cancer for both men and women, estimating >150K CRC cases in the US in 2024. We are building blood tests designed to screen for CRC, aiming to help patients detect CRC earlier in its more treatable stages.

Freenome was founded in 2014, and now in 2024, we are entering in our next decade with a refreshed look. We remain committed to outpacing cancer through early detection, by combining the latest in science and AI to create accessible screening tests.

Visit freenome.com

In observance of Colorectal Cancer Awareness Month, we reaffirm our commitment to battling colorectal cancer (CRC) through our work building early cancer detection blood tests.

Throughout March, we'll share more about CRC, and show the potential of #earlydetection to save lives.

Announcing a $254 million funding round led by @Roche alongside existing and new investors. This will accelerate Freenome’s efforts to advance early cancer detection.

Full PR:
freenome.com/news/freenome-…